JBM (Healthcare) Ltd. (HK:2161) has released an update.
JBM (Healthcare) Limited has scheduled a Board meeting for June 18, 2024, to discuss and approve the company’s final results for the fiscal year ending March 31, 2024. The meeting will also consider the possibility of recommending a final dividend to shareholders. This strategic move signifies potential impacts on the company’s financial health and shareholder value.
For further insights into HK:2161 stock, check out TipRanks’ Stock Analysis page.
